(Q36891819)

16 August 2017

1 reference

title

New perspectives for the treatment of disorders of sleep and arousal (English)

1 reference

16 August 2017

Sanger DJ

1

1 reference

PubMed ID

17652996

16 August 2017

Soubrane C

series ordinal

2

1 reference

PubMed ID

17652996

16 August 2017

Scatton B

series ordinal

3

1 reference

16 August 2017

1 July 2007

1 reference

Annales pharmaceutiques françaises

16 August 2017

1 reference

16 August 2017

65

1 reference

16 August 2017

4

1 reference

16 August 2017

268-274

1 reference

New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

New insights into the mechanism of action of hypnotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

The Pharmacology and Mechanism of Action of Zolpidem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Treating insomnia: Current and investigational pharmacological approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Indiplon: the development of a new hypnotic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

The benzodiazepine binding site of GABA A receptors as a target for the development of novel anxiolytics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Zolpidem extended-release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Serotonin-2 receptors and human sleep: effect of a selective antagonist on EEG power spectra.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Effects of antiepileptic drugs on sleep structure : are all drugs equal?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Emerging pharmacotherapeutic agents for insomnia: a hypnotic panacea?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

A Systematic Review of Modafinil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Sodium oxybate for narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Hypocretins (orexins) and sleep-wake disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

The brain's master circadian clock: implications and opportunities for therapy of sleep disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Promoting adjustment of the sleep-wake cycle by chronobiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Melatonin: Nature's most versatile biological signal?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

Agomelatine: a preliminary review of a new antidepressant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2807%2990046-2

10.1016/S0003-4509(07)90046-2

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17652996